These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 11871363)
21. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. Ferguson GT; Karpel J; Bennett N; Clerisme-Beaty E; Grönke L; Voß F; Buhl R NPJ Prim Care Respir Med; 2017 Feb; 27(1):7. PubMed ID: 28154373 [TBL] [Abstract][Full Text] [Related]
22. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease. Oostenbrink JB; Rutten-van Mölken MP; Al MJ; Van Noord JA; Vincken W Eur Respir J; 2004 Feb; 23(2):241-9. PubMed ID: 14979498 [TBL] [Abstract][Full Text] [Related]
23. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease]. Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014 [TBL] [Abstract][Full Text] [Related]
24. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Celli B; ZuWallack R; Wang S; Kesten S Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043 [TBL] [Abstract][Full Text] [Related]
25. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677 [TBL] [Abstract][Full Text] [Related]
26. [The efficacy and safety of low-dose tiotropium bromide inhaled via Respimat® in patients with chronic obstructive pulmonary disease]. Ma J; Zhou Z; Tang Y; Zhong N Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):964-8. PubMed ID: 25623564 [TBL] [Abstract][Full Text] [Related]
27. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M; Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426 [TBL] [Abstract][Full Text] [Related]
28. Additive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroids. Perng DW; Wu CC; Su KC; Lee YC; Perng RP; Tao CW Respirology; 2006 Sep; 11(5):598-602. PubMed ID: 16916333 [TBL] [Abstract][Full Text] [Related]
29. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Farne HA; Cates CJ Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945 [TBL] [Abstract][Full Text] [Related]
30. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338 [TBL] [Abstract][Full Text] [Related]
31. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761 [TBL] [Abstract][Full Text] [Related]
32. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Calverley PM; Lee A; Towse L; van Noord J; Witek TJ; Kelsen S Thorax; 2003 Oct; 58(10):855-60. PubMed ID: 14514937 [TBL] [Abstract][Full Text] [Related]
33. [Efficacy and Safety of Tiotropium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease--a Multi-center Randomized Clinical Trial]. Luo Z; Liu CT; Wu CG; Xia QM; Yang L; Huang JA; Ying KJ; Wu GM; Cui SH Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):485-7. PubMed ID: 26121878 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Niewoehner DE; Lapidus R; Cote C; Sharafkhaneh A; Plautz M; Johnson P; Kesten S Pulm Pharmacol Ther; 2009 Dec; 22(6):587-92. PubMed ID: 19737620 [TBL] [Abstract][Full Text] [Related]
35. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
36. Exacerbation frequency and course of COPD. Halpin DM; Decramer M; Celli B; Kesten S; Liu D; Tashkin DP Int J Chron Obstruct Pulmon Dis; 2012; 7():653-61. PubMed ID: 23055714 [TBL] [Abstract][Full Text] [Related]
37. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. Bateman ED; van Dyk M; Sagriotis A Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684 [TBL] [Abstract][Full Text] [Related]
39. Tiotropium: a potential replacement for ipratropium in patients with COPD. Shukla VK Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]